RapidAI Announces $75 Million Growth Investment Led By Vista Credit Partners

Funding Intended to Fuel Continued Innovation of RapidAI’s Advanced Clinical Decision and Workflow Support Technology Further Establish a Leadership Position in Clinical AI Solutions RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data, and technology markets. The funding aims to drive platform innovation to support more disease states and go-to-market functions to accelerate growth in new regions and product verticals. “Hospitals are increasingly looking for RapidAI solutions to solve their critical needs, including helping care teams work more efficiently and support clinical decision-making for better patient outcomes,” said Karim Karti, CEO at RapidAI. “RapidAI’s advanced clinical decision support (CDS) software goes beyond simple triage and notification to provide specific, relevant, and contextual data with tremendous accuracy to satisfy these demands. Vista Credit Partners’ support and access to their expertise will advance our vision, technological innovation, and go-to-market efforts as we further establish our leadership position in clinical AI solutions for life-threatening diseases.” RapidAI’s pioneering AI and workflow technology sets the s...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT David Flannery Health IT Funding Health IT Fundings Health IT Investment Karim Karti RapidAI UBS Securities LLC Vista Credit Partners Vista Equity Partners Source Type: blogs